Schistosomiasis vaccine development: update on human clinical trials
Abstract Schistosomiasis causes significant levels of morbidity and mortality in many geographical regions of the world. The disease is caused by infections with parasitic blood flukes known as schistosomes. The control of schistosomiasis over the last several decades has been centered on the mass d...
Main Author: | Adebayo J. Molehin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-020-0621-y |
Similar Items
-
A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis
by: J.E. Truscott, et al.
Published: (2017-03-01) -
Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development
by: Molehin AJ
Published: (2020-11-01) -
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects
by: Adebayo J. Molehin, et al.
Published: (2022-02-01) -
Mass drug administration and the sustainable control of schistosomiasis: an evaluation of treatment compliance in the rural Philippines
by: Marianette T. Inobaya, et al.
Published: (2018-07-01) -
Schistosomiasis in School Age Children in Sierra Leone After 6 Years of Mass Drug Administration With Praziquantel
by: Yakuba M. Bah, et al.
Published: (2019-02-01)